<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/262838-extended-release-formulation-of-cyclobenzaprine by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 03:19:55 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 262838:EXTENDED RELEASE FORMULATION OF CYCLOBENZAPRINE</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">EXTENDED RELEASE FORMULATION OF CYCLOBENZAPRINE</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The present invention provides an extended release formulation comprising therapeutically effective amount of cyclobenzaprine, at least one water soluble polymeric release retardant, and at least one pharmaceutically acceptable excipient; optionally along with non-polymeric release retardant. The invention further relates to method of preparation for extended release cyclobenzaprine formulation which exhibits unique dissolution profile formulation over desirable time period.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>FORM 2<br>
THE PATENTS ACT, 1970<br>
(39 of 1970)<br>
&amp;<br>
THE PATENTS RULES, 2003<br>
PROVISIONAL SPECIFICATION<br>
(See section 10 and rule 13]<br><br><br><br>
1.	Title of the invention: "Extended release formulation of Cyclobenzaprine"<br>
2.	Macleods Pharmaceuticals Ltd., an Indian Company, having its Registered Office at 304 - Atlanta Arcade, Opp. Leela Hotel, Marol Church Road, Andheri (East), Mumbai - 400 059, Maharashtra, India.<br>
3.	The following specification describes the invention.<br><br><br><br>
EXTENDED RELEASE FORMULATION OF CYCLOBENZAPRINE<br>
TECHNICAL FIELD:<br>
The present invention provides an extended release dosage form of Cyclobenzaprine, a skeletal muscle relaxant and method of preparation of the same.<br>
BACKGROUND OF INVENTION:<br>
Many therapeutic agents are most effective when made available at a constant rate at or near the absorption site. The absorption of therapeutic agents thus made available generally results in desired plasma concentrations leading to maximum efficacy and minimum toxic side effects. Much effort has been devoted to developing matrix tablet based and multi-particulate capsule based drug delivery systems for oral applications.<br>
US Patent 7287793 discloses a multiparticulate pharmaceutical dosage form of a<br>
skeletal muscle relaxant providing a modified release profile comprising a population<br>
of extended release beads, wherein said extended release beads comprise active<br>
containing core particles comprising a skeletal muscle relaxant and extended release<br>
coating comprising a water insoluble polymer membrane surrounding said core,<br>
wherein said dosage form when dissolution tested using USP apparatus 2 at 50 rpm in<br>
900ml of 0.1 N HCL at 37°C, exhibit a drug release profile substantially corresponding<br>
to the following pattern:<br>
After 2 hrs, not more than about 40% of the total active is released,<br>
After 4 hrs, from about 40-65% of the total active is released,<br>
After 8 hrs, from about 65-85% of the total active is released,<br>
Water insoluble controlled release membrane can also comprise water-soluble polymer.<br>
1<br><br>
BRIEF DESCRIPTION OF THE INVENTION:<br>
The present invention provides an extended release dosage form of Cyclobenzaprine, a<br>
skeletal muscle relaxant.<br>
According to present invention the extended release dosage form may be in the form of<br>
1)	Inert core coated with first drug layer with binder, further comprise a water soluble seal coat and a control release coating of water insoluble polymer, or<br>
2)	Core containing drug along with binder and filler which further comprise of control release coating of water soluble polymer, or<br>
3)	Core containing drug along with binder and filler and further comprise of water insoluble polymer coating, or<br>
4)	A controlled release core comprising drug, binder, filler, control release water insoluble polymer and coated with nonfunctional water soluble coating, or<br>
5)	Core in the form of tablet comprising binder, filler, lubricant, control release water soluble polymer and a water soluble seal coat and a final coating comprising mixture of water soluble and water insoluble polymer, or<br>
6)	Core in the form of 4 minitablets comprising binder, filler, lubricant, control release water soluble polymer and a water soluble seal coat. Out of 4 minitablets three tablets were given controlled release coating comprising mixture of water soluble and water insoluble polymer with different percentage to provide extended release. Fourth tablet provide an initial dose.<br>
The core is then finally filled in to the capsules.<br>
2<br><br>
The present invention can be illustrated by the following examples:<br>
A: Examples of core comprising pellets<br>
Example 1 - Drug &amp; Functional Coating on Inert Pellets (F1-F4)<br>
•	Core Pellets - MCC or sugar spheres<br>
•	Drug layer<br><br>
-	Cyclobenzaprine HC1<br>
-	HPMC<br>
-	DBP<br>
-	Water<br>
•	Seal Coating<br>
-	HPMC<br>
-	DBP<br>
-	Water<br>
•	Functional Coating<br>
-	Ethyl Cellulose<br>
-	DBS<br>
-	Water<br>
Finally the coated beads are filled into capsules Formula -1) Core Pellets coated with drug.<br><br>
Ingredients (mg per tablet)	Batch No.<br><br>
	Fl	F2	F3	F4<br>
Drug coating Solution<br>
Sugar spheres (18-20 mesh) Cyclobenzaprine HC1 HPMC E-5 LV Water*	98.5 10 1.5 37	87 20 3.0 74	75.5 30 4.5 111	64<br>
40<br>
6<br>
128<br><br>
Total weight (mg)	110	110	110	110<br>
Seal coat (2 % weight gain)<br>
HPMC E-5 LV Polyethylene glycol-400 Water*	2.0 0.2 qs	2.0 0.2<br>
qs	2.0 0.2 qs	2.0 0.2 qs<br>
Control release coating (1^	% weight gain)<br>
Ethyl cellulose (30 % dispersion)<br>
Dibutyl sebacate<br>
Water*	14.44 1.26<br>
qs	14.44<br>
1.26<br>
qs	14.44<br>
1.26<br>
qs	14.44 1.26 qs<br>
* Not present in the end product.<br>
Process:<br>
1.	Inert core pellets are coated with drug solution.<br>
2.	Drug coated pellets are seal coated with HPMC solution.<br>
3.	Seal coated pellets are coated with Ethyl Cellulose.<br>
4.	Ethyl Cellulose coated pellets are filled in suitable size capsule shell.<br>
Example 2 - Core pellets containing drug &amp; coating with water-soluble polymer<br>
(F5-F8)<br><br>
Ingredients (mg per tablet)	Batch No.<br><br>
	F5	F6	F7	F8<br>
Cyclobenzaprine HCl MCCPHIOI HPMC E-5 LV Water*	10 120 1.2 qs	20 110 1.2 qs	30 100 1.2 qs	40 90 1.2 qs<br>
Total weight (mg)	131.2	131.2	131.2	131.2<br>
Water-soluble coat (20%)<br><br>
HPMC K4 M	23.67	23.67	23.67	23.67<br>
Polyethylene glycol-400	2.63	2.63	2.63	2.63<br>
Water*	qs	qs	qs	qs<br>
* Not present in the end product. Process:<br>
1)	Cyclobenzaprine HCl, MCC PH 101 and HPMC is mixed &amp; granulated with water to form a plastic mass.<br>
2)	This mass was Extruded &amp; Spheronized.<br>
3)	Coat the drug spheres with water-soluble HPMC solution.<br>
Example 3 - Core pellets containing drug &amp; Coating with water insoluble polymer<br><br>
(F9-F16).<br><br>
Ingredients (mg per tablet)	Batch No.<br><br>
	F9	F10	Fll	F12<br>
Cyclobenzaprine HCl MCCPH 101 HPMC E-5 LV Water*	10 120 1.2 qs	20<br>
110<br>
1.2<br>
qs	30 100 1.2 qs	40 90 1.2<br>
qs<br>
Total weight (mg)	131.2	131.2	131.2	131.2<br>
Water insoluble coat (14%)<br>
Hydrogenated vegetable oil Dibutyl sebacate	16.52 1.84	16.52 1.84	16.52 1.84	16.52 1.84<br><br>
Ingredients (mg per tablet)	Batch No.<br><br>
	F13	F14	F15	F16<br>
Cyclobenzaprine HCl MCCPH 101 HPMC E-5 LV	10 120 1.2	20<br>
110<br>
1.2	30<br>
100<br>
1.2	40 90 1.2<br><br>
5<br><br>
Water*	qs	qs	qs	qs<br>
Total weight (mg)	131.2	131.2	131.2	131.2<br>
Water insoluble coat (14%)<br>
Hydrogenated castor oil Dibutyl sebacate	16.52 1.84	16.52 1.84	16.52 1.84	16.52 1.84<br>
* Not present in the end product. Process:<br>
1)	Cyclobenzaprine HCL MCC PH 10land HPMC is mixed &amp; granulated with water to form a plastic mass.<br>
2)	This mass was Extruded &amp; Spheronized.<br>
3)	Coat the drug spheres with water insoluble polymer dispersion.<br>
Example 4-Core pellets containing controlled release drug and coating with non¬functional coating (F17-F20).<br><br>
Ingredients (mg per tablet)	Batch No.<br><br>
	F17	F18	F19	F20<br>
Cyclobenzaprine HCl<br>
MCC PH 101<br>
HPMC E-5 LV<br>
Ethyl cellulose (30% dispersion)<br>
Water*	10 120 1.2 10 qs	20<br>
110<br>
1.2<br>
10<br>
qs	30<br>
100<br>
1.2<br>
10<br>
qs	40 90 1.2 10 qs<br>
Total weight (mg)	141.2	141.2	141.2	141.2<br>
Water-soluble coat (1.6 %)<br>
HPMC E-5 LV Polyethylene glycol-400 Water*	2.0 0.2 qs	2.0 0.2<br>
qs	2.0 0.2 qs	2.0 0.2 qs<br>
* Not present in the end product.<br>
6<br><br>
Process:<br>
1)	Cyclobenzaprine HCl, MCC PH 101, and HPMC was mixed &amp; granulated with Ethyl cellulose solution to form a plastic mass.<br>
2)	This mass was Extruded &amp; Spheronized.<br>
3)	Coat the drug spheres with HPMC solution.<br>
B: Examples of core comprising tablet or minitablets.<br>
Example 5: CR oral tablets in capsules (F1-F8) 1) a) Core tablets using HPMC K4 MCR<br><br>
Ingredients (mg per tablet)	Batch No.<br><br>
	Fl	F2	F3	F4<br>
Cyclobenzaprine HCl<br>
Mannitol<br>
HPMC K4M CR<br>
P.V.P.K30<br>
I.P.A<br>
Magnesium Stearate	10<br>
87.3<br>
5<br>
6.5 qs 1.2	20<br>
77.3<br>
5<br>
6.5 qs 1.2	30<br>
67.3<br>
5<br>
6.5 qs 1.2	40<br>
57.3<br>
5<br>
6.5 qs 1.2<br>
Total weight	110	110	110	110<br>
1) b) Core tablets using PEO-WSR<br><br>
Ingredients (mg per tablet)	Batch No.<br><br>
	F5	F6	F7	F8<br>
Cyclobenzaprine HCl<br>
Mannitol<br>
Polyethylene oxide-WSR<br>
P.V.P.K30	10<br>
87.3<br>
5<br>
6.5	20<br>
77.3<br>
5<br>
6.5	30<br>
67.3<br>
5<br>
6.5	40<br>
57.3<br>
5<br>
6.5<br>
7<br><br>
I.P.A<br>
Magnesium Stearate	qs 1.2	qs<br>
1.2	qs 1.2	qs 1.2<br>
Total weight	no	no	110	no<br>
2)	Seal Coating<br>
Opadry clear YS - IR 7006 [HPMC Based) - 1.5% on core<br>
3)	Ethyl Cellulose + HPMC Coating - 6% on seal coating<br>
Composition   - Ethyl Cellulose HPMC DBS Acetone Water<br>
Process:<br>
2.	Dry mix Cyclobenzaprine, Mannitol, HPMC K4M C or PEO-WSR.<br>
3.	Dissolve PVP K30 in I.P.A to get clear solution<br>
4.	Granulate the dry mix of step 1 with the binder solution of step 2<br>
5.	Wet mill, dry &amp; size the granules.<br>
6.	Dried granules are lubricated with magnesium Stearate and compressed to tablets using suitable punches.<br>
7.	Compressed tablets are seal coated with Opadry and finally coated with EC + HPMC coating solution.<br><br>
Example 6: Multi tablets in capsules (F9-F12) 1) Core tablets<br><br>
Ingredients (mg per tablet)	Batch No.<br><br>
	F9	F10	Fll	F12<br>
Cyclobenzaprine HC1<br>
Mannitol<br>
HPMC K4M CR<br>
P.V.P.K 30<br>
I.P.A<br>
Magnesium Stearate	10<br>
87.3<br>
5<br>
6.5 qs 1.2	20<br>
77.3<br>
5<br>
6.5<br>
qs 1.2	30<br>
67.3<br>
5<br>
6.5 qs 1.2	40<br>
57.3 5<br>
6.5 qs 1.2<br>
Total weight *	110	110	110	110<br>
* Four mini tablets weighing approximately 27.5 mg have to be compressed.<br>
2)	Seal Coating<br>
Opadry clear YS - IR 7006 [HPMC Based) - 1.5% on core tablets.<br>
3)	Ethyl Cellulose + HPMC Coating (85:15) - 1 tablet without CR coat, second<br>
with 6%, third with 9 % and fourth tablet with 12 % CR coat on seal coated<br>
tablets.<br>
Composition   - Ethyl Cellulose<br>
HPMC<br>
DBS<br>
Acetone<br>
Water<br>
9<br><br>
Process:<br>
1.	Dry mix Cyclobenzaprine, Mannitol, HPMC K4M CR,<br>
2.	Dissolve PVP K30 in I.P.A to get clear solution<br>
3.	Granulate the dry mix of step 1 with the binder solution of step 2<br>
4.	Wet mill, dry &amp; size the granules.<br>
5.	Dried granules are lubricated with magnesium Stearate and compressed to mini tablets using suitable punches.<br>
6.	Compressed mini tablets are seal coated with Opadry and finally coated with EC + HPMC coating solution.<br>
10<br><br><br>
11<br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LU1VTS0yMDA5LUFCU1RSQUNUKDEyLTMtMjAxMCkucGRm" target="_blank" style="word-wrap:break-word;">534-MUM-2009-ABSTRACT(12-3-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LU1VTS0yMDA5LUNMQUlNUygxMi0zLTIwMTApLnBkZg==" target="_blank" style="word-wrap:break-word;">534-MUM-2009-CLAIMS(12-3-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LU1VTS0yMDA5LUNMQUlNUyhBTUVOREVEKS0oMTctNi0yMDE0KS5wZGY=" target="_blank" style="word-wrap:break-word;">534-MUM-2009-CLAIMS(AMENDED)-(17-6-2014).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LU1VTS0yMDA5LUNMQUlNUyhBTUVOREVEKS0oNS03LTIwMTMpLnBkZg==" target="_blank" style="word-wrap:break-word;">534-MUM-2009-CLAIMS(AMENDED)-(5-7-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LU1VTS0yMDA5LUNMQUlNUyhNQVJLRUQgQ09QWSktKDE3LTYtMjAxNCkucGRm" target="_blank" style="word-wrap:break-word;">534-MUM-2009-CLAIMS(MARKED COPY)-(17-6-2014).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LU1VTS0yMDA5LUNMQUlNUyhNQVJLRUQgQ09QWSktKDUtNy0yMDEzKS5wZGY=" target="_blank" style="word-wrap:break-word;">534-MUM-2009-CLAIMS(MARKED COPY)-(5-7-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LU1VTS0yMDA5LUNPUlJFU1BPTkRFTkNFKDEyLTMtMjAxMCkucGRm" target="_blank" style="word-wrap:break-word;">534-MUM-2009-CORRESPONDENCE(12-3-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LU1VTS0yMDA5LUNPUlJFU1BPTkRFTkNFKDE3LTYtMjAxNCkucGRm" target="_blank" style="word-wrap:break-word;">534-MUM-2009-CORRESPONDENCE(17-6-2014).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LU1VTS0yMDA5LUNPUlJFU1BPTkRFTkNFKElQTyktKDI4LTgtMjAwOSkucGRm" target="_blank" style="word-wrap:break-word;">534-MUM-2009-CORRESPONDENCE(IPO)-(28-8-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LU1VTS0yMDA5LURFU0NSSVBUSU9OKENPTVBMRVRFKS0oMTItMy0yMDEwKS5wZGY=" target="_blank" style="word-wrap:break-word;">534-MUM-2009-DESCRIPTION(COMPLETE)-(12-3-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LW11bS0yMDA5LWRlc2NyaXB0aW9uKHByb3Zpc2lvbmFsKS5kb2M=" target="_blank" style="word-wrap:break-word;">534-mum-2009-description(provisional).doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LW11bS0yMDA5LWRlc2NyaXB0aW9uKHByb3Zpc2lvbmFsKS5wZGY=" target="_blank" style="word-wrap:break-word;">534-mum-2009-description(provisional).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LW11bS0yMDA5LWZvcm0gMS5wZGY=" target="_blank" style="word-wrap:break-word;">534-mum-2009-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LU1VTS0yMDA5LUZPUk0gMTgoMjItMTAtMjAxMCkucGRm" target="_blank" style="word-wrap:break-word;">534-MUM-2009-FORM 18(22-10-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LW11bS0yMDA5LWZvcm0gMigxMi0zLTIwMTApLnBkZg==" target="_blank" style="word-wrap:break-word;">534-mum-2009-form 2(12-3-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LU1VTS0yMDA5LUZPUk0gMihUSVRMRSBQQUdFKS0oMTItMy0yMDEwKS5wZGY=" target="_blank" style="word-wrap:break-word;">534-MUM-2009-FORM 2(TITLE PAGE)-(12-3-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LU1VTS0yMDA5LUZPUk0gMihUSVRMRSBQQUdFKS0oUFJPVklTSU9OQUwpLSgxMi0zLTIwMDkpLnBkZg==" target="_blank" style="word-wrap:break-word;">534-MUM-2009-FORM 2(TITLE PAGE)-(PROVISIONAL)-(12-3-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LW11bS0yMDA5LWZvcm0gMih0aXRsZSBwYWdlKS5wZGY=" target="_blank" style="word-wrap:break-word;">534-mum-2009-form 2(title page).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LW11bS0yMDA5LWZvcm0gMi5kb2M=" target="_blank" style="word-wrap:break-word;">534-mum-2009-form 2.doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LW11bS0yMDA5LWZvcm0gMi5wZGY=" target="_blank" style="word-wrap:break-word;">534-mum-2009-form 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LW11bS0yMDA5LWZvcm0gMy5wZGY=" target="_blank" style="word-wrap:break-word;">534-mum-2009-form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LW11bS0yMDA5LWZvcm0gNS5wZGY=" target="_blank" style="word-wrap:break-word;">534-mum-2009-form 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LU1VTS0yMDA5LVJFUExZIFRPIEVYQU1JTkFUSU9OIFJFUE9SVCg1LTctMjAxMykucGRm" target="_blank" style="word-wrap:break-word;">534-MUM-2009-REPLY TO EXAMINATION REPORT(5-7-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTM0LU1VTS0yMDA5LVJFUExZIFRPIEhFQVJJTkcoMTctNi0yMDE0KS5wZGY=" target="_blank" style="word-wrap:break-word;">534-MUM-2009-REPLY TO HEARING(17-6-2014).pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="262837-an-improved-process-for-preparation-of-tetrahydro-n-3-methylamino-propyl-2-furan-carboxamide.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="262839-arrangement-in-connection-with-an-oscillator-cylinder.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>262838</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>534/MUM/2009</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>39/2014</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>26-Sep-2014</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>18-Sep-2014</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>12-Mar-2009</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>MACLEODS PHARMACEUTICALS LIMITED</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>304, ATLANTA ARCADE, OPP. LEELA HOTEL, MAROL CHURCH ROAD, ANDHERI(EAST), MUMBAI</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>AGARWAL RAJENDRA MURLIDHAR</td>
											<td>G-2, MAHAKALI CAVES ROAD, SHANTI NAGAR, ANDHERI (EAST), MUMBAI-400093,</td>
										</tr>
										<tr>
											<td>2</td>
											<td>MAHESHWARI HITESH KUMAR</td>
											<td>G-2, MAHAKALI CAVES ROAD, SHANTI NAGAR, ANDHERI (EAST), MUMBAI-400093,</td>
										</tr>
										<tr>
											<td>3</td>
											<td>RIDHURKAR DEVENDRA</td>
											<td>G-2, MAHAKALI CAVES ROAD, SHANTI NAGAR, ANDHERI (EAST), MUMBAI-400093,</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>A61K9/20</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>N/A</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td></td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td></td>
									<td></td>
								    <td>NA</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/262838-extended-release-formulation-of-cyclobenzaprine by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 03:19:56 GMT -->
</html>
